Open Data 5 Years On: A Case Series of 12 Freedom of Information Requests for Regulatory Data to the European Medicines Agency

Trials - United Kingdom
doi 10.1186/s13063-016-1194-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Intersection of Open Data and Freedom of Information Practice in Nigeria

eJournal of eDemocracy and Open Government
Computer Science ApplicationsSociologyPolitical Science
2017English

What Is the European Medicines Agency?

Epidemiology and Psychiatric Sciences
Mental HealthEpidemiologyPublic HealthEnvironmentalPsychiatryOccupational Health
2012English

Improving the Contribution of Regulatory Assessment Reports to Health Technology Assessments—A Collaboration Between the European Medicines Agency and the European Network for Health Technology Assessment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

European Medicines Agency Workshop on Biosimilar Monoclonal Antibodies

mAbs
AllergyImmunology
2009English

Compilation of Requests for Nuclear Data

1993English

The European Medicines Agency Facilitates Access to Medicines in Low- And Middle-Income Countries

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2020English

Industrial Open Data: Case Studies of Early Open Data Entrepreneurs

2014English

FDA Reform and the European Medicines Evaluation Agency

Harvard Law Review
Law
1995English

More Transparency for Clinical Trial Data: The Decision by the European Medicines Agency to Make Clinical Trial Reports Publicly Available Could Provide a Boon for Biomedical Research

EMBO Reports
BiochemistryGeneticsMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy